Management of Patients With Refractory Reflux‐Like Symptoms Despite Proton Pump Inhibitor Therapy: Evidence‐Based Consensus Statements
The management of rRLS should be personalised, based on shared decision-making regarding the role of diagnostic testing to confirm or rule out GERD as a basis for treatment optimisation. Anti-reflux procedures should not be performed without objective confirmation of GERD.
Authors
- Reginald C. W. Bell (ORCID: https://orcid.org/0000-0002-7912-4000)
- Adriana Lazarescu
- Sama Anvari (ORCID: https://orcid.org/0000-0002-7284-8735)
- David Armstrong (ORCID: https://orcid.org/0000-0003-2487-1479)
- Peter Katelaris (ORCID: https://orcid.org/0000-0001-6969-4328)
- Alessandro Repici (ORCID: https://orcid.org/0000-0002-1621-6450)
- Frank Zerbib (ORCID: https://orcid.org/0000-0002-6802-2121)
- Rena H. Yadlapati (ORCID: https://orcid.org/0000-0002-7872-2033)
- Sabine Roman (ORCID: https://orcid.org/0000-0002-7798-7638)
- Kentaro Sugano (ORCID: https://orcid.org/0000-0002-8578-2974)
- Yeong Yeh Lee (ORCID: https://orcid.org/0000-0002-6486-7717)
- Daniel Sifrim (ORCID: https://orcid.org/0000-0002-4894-0523)
- Paul Moayyedi (ORCID: https://orcid.org/0000-0002-3616-9292)
- Sameer Al Awadhi (ORCID: https://orcid.org/0000-0002-1611-3451)
- Yuhong Yuan (ORCID: https://orcid.org/0000-0003-4374-3042)
- Brendan Delaney (ORCID: https://orcid.org/0000-0002-3518-0131)
- Chandra Prakash Gyawali (ORCID: https://orcid.org/0000-0002-3388-0660)
- Edoardo Vincenzo Savarino (ORCID: https://orcid.org/0000-0002-3187-2894)
- Peter J. Kahrilas (ORCID: https://orcid.org/0000-0002-8260-1250)
- A. P. S. Hungin (ORCID: https://orcid.org/0000-0001-7275-8927)
- Ceciel Rooker
- Fabián Emura (ORCID: https://orcid.org/0000-0002-6544-1435)
- Prateek Sharma (ORCID: https://orcid.org/0000-0001-5646-8727)
- Paul Sinclair (ORCID: https://orcid.org/0000-0003-1085-1645)
- Michael F. Vaezi (ORCID: https://orcid.org/0000-0003-3179-0212)
Institutions
- Northwestern University (US)
- The University of Sydney (AU)
- University of Padua (IT)
- University of Miami (US)
- University of Kansas (US)
- Jichi Medical University (JP)
- Université de Bordeaux (FR)
- University of Alberta (CA)
- Inserm (FR)
- Universidad de La Sabana (CO)
- Queen Mary University of London (GB)
- Washington University in St. Louis (US)
- Concord Repatriation General Hospital (AU)
- Rashid Hospital (AE)
- Population Health Research Institute (CA)
- Centre Hospitalier Universitaire de Bordeaux (FR)
- University of California San Diego (US)
- Hospital Universiti Sains Malaysia (MY)
- Hôpital Lyon Sud (FR)
- Hôpital Cardiologique du Haut-Lévêque (FR)
- International Foundation for Functional Gastrointestinal Disorders (US)
- Kansas City VA Medical Center (US)
- IRCCS Humanitas Research Hospital (IT)
- Centre d'Investigation Clinique Plurithématique de Bordeaux
- Imperial College London (GB)
- Newcastle University (GB)
- Vanderbilt University Medical Center (US)
- McMaster University (CA)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2024-12-30
- DOI
- https://doi.org/10.1111/apt.18420
- Citations
- 7
- Primary Topic
- Gastroesophageal reflux and treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.25
Funders
- Sanofi
- Boston Scientific Corporation
- Intuitive Surgical
- Ironwood Pharmaceuticals, Incorporated
- Dr. Falk Pharma
- Samsung
- Ethicon Endo-Surgery